Xiaobin Wu News Today

BeiGene (NASDAQ:BGNE – Free Report) had its price target cut by Morgan Stanley from $321.00 to $319.00 in a research note released on Tuesday, Benzinga reports. They currently have an overweight rating on the stock. A number of other analysts have also weighed in on BGNE. 22nd Century Group reaffirmed a downgrade rating on shares […]

StockNews.com started coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the stock. Other equities analysts have also recently issued reports about the stock. JPMorgan Chase & Co. raised their target price on shares of BeiGene from $297.00 to $300.00 and […]

Equities researchers at Jefferies Financial Group started coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $287.00 price target on the stock. Jefferies Financial Group’s price objective points to a potential upside of 49.22% from the company’s […]

BeiGene (NASDAQ:BGNE – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($3.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.47) by ($0.17), Briefing.com reports. BeiGene had a negative net margin of 123.48% and a negative return on equity of 41.58%. The business had revenue of […]

BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been given an average rating of “Moderate Buy” by the nine brokerages that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target price among brokers […]

China Universal Asset Management Co. Ltd. raised its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 18.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 577 shares of the company’s stock after purchasing an additional 91 shares […]

Shares of BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $192.53, but opened at $182.61. BeiGene shares last traded at $184.41, with a volume of 50,571 shares traded. Wall Street Analysts Forecast Growth BGNE has been the topic of several recent […]

Shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight research firms that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average […]

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) COO Xiaobin Wu sold 3,291 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $224.73, for a total transaction of $739,586.43. The sale was disclosed in a legal filing with the SEC, which can be […]

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) has received an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month target price among brokerages that […]